Anne Li April 23rd, 2017
Scotland has become the first part of the UK to make a drug routinely available on the NHS that can extend the lives of women with an aggressive form of breast cancer. Kadcyla was approved by the Scottish Medicines Consortium (SMC), which assesses drugs for use by the health service in Scotland, in a decision welcomed by charities and doctors. But the move has highlighted differences in health policy between the UK nations and has led to calls for access for patients in England.
See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-04-11-breast-cancer-drug-approved-for-use-in-scotland-though-concerns-remain-about-patients-getting-the